衞寧健康(300253.SZ)擬以5000萬元增資鑰世圈 持股將由42.1737%增至45.7044%
格隆匯5月12日丨衞寧健康(300253.SZ)公佈,公司控股子公司上海鑰世圈雲健康科技發展有限公司(“鑰世圈”、“目標公司”)根據業務發展需要擬由部分原股東進行增資,將其註冊資本由8905.1442萬元增至10127.4189萬元。其中,公司以自有資金人民幣5000萬元認繳新增註冊資本873.0533萬元,蘇州千驥澤康投資中心(有限合夥)以現金人民幣1090.0602萬元認繳註冊資本190.3361萬元,上海千驥康澤投資中心(有限合夥)以現金人民幣909.9398萬元認繳註冊資本158.8852萬元。
此次增資後公司持有鑰世圈的股權將由42.1737%增至45.7044%,鑰世圈仍為公司控股子公司。
鑰世圈為公司控股子公司,通過“醫藥健險聯合運營”SaaS服務平台RiNGNEX,打通院內到院外醫、藥、健、險運營體系,實現醫療機構、藥品企業、零售藥房、商業保險、健康管理服務的全價值鏈接,與生態夥伴組成生態共同體,實現生態共贏。
此次增資有利於滿足鑰世圈業務發展對流動資金的需求,降低融資成本,促進RiNGNEX平台的推廣和深入,對公司未來發展具有積極作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.